These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 8791135
1. Tumoral vascularity as a prognostic factor in cancer. Weidner N, Folkman J. Important Adv Oncol; 1996; ():167-90. PubMed ID: 8791135 [No Abstract] [Full Text] [Related]
2. Regulation of angiogenesis via vascular endothelial growth factor receptors. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Cancer Res; 2000 Jan 15; 60(2):203-12. PubMed ID: 10667560 [No Abstract] [Full Text] [Related]
3. The contribution of proangiogenic factors to the progression of malignant disease: role of vascular endothelial growth factor and its receptors. Neufeld G, Kessler O, Vadasz Z, Gluzman-Poltorak Z. Surg Oncol Clin N Am; 2001 Apr 15; 10(2):339-56, ix. PubMed ID: 11382591 [Abstract] [Full Text] [Related]
4. [Tumor progression and angiogenesis]. Maru Y. Gan To Kagaku Ryoho; 1999 Sep 15; 26(10):1509-19. PubMed ID: 10500543 [Abstract] [Full Text] [Related]
5. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Nat Rev Cancer; 2002 Nov 15; 2(11):826-35. PubMed ID: 12415253 [No Abstract] [Full Text] [Related]
6. [Angiogenesis and tumor growth. Angiogenic factors and tumor growth]. Plouet J. Ann Pathol; 1999 Nov 15; 19(5 Suppl):S70-1. PubMed ID: 10599456 [No Abstract] [Full Text] [Related]
7. Angiogenesis and antiangiogenic therapy. Sledge GW, Miller KD. Curr Probl Cancer; 2002 Nov 15; 26(1):1-60. PubMed ID: 11961506 [No Abstract] [Full Text] [Related]
8. New developments in angiogenesis: a major mechanism for tumor growth and target for therapy. Jones A, Harris AL. Cancer J Sci Am; 1998 Nov 15; 4(4):209-17. PubMed ID: 9689977 [No Abstract] [Full Text] [Related]
13. The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities. Siemeister G, Martiny-Baron G, Marmé D. Cancer Metastasis Rev; 1998 Jun 15; 17(2):241-8. PubMed ID: 9770121 [No Abstract] [Full Text] [Related]
14. VEGFs, receptors and angiogenesis. Veikkola T, Alitalo K. Semin Cancer Biol; 1999 Jun 15; 9(3):211-20. PubMed ID: 10343072 [Abstract] [Full Text] [Related]
16. Formation of endothelial cell networks. Helmlinger G, Endo M, Ferrara N, Hlatky L, Jain RK. Nature; 2000 May 11; 405(6783):139-41. PubMed ID: 10821260 [No Abstract] [Full Text] [Related]
17. Vascular endothelial growth factor as a target for antiangiogenic therapy. Gordon MS. J Clin Oncol; 2000 Nov 01; 18(21 Suppl):45S-6S. PubMed ID: 11060326 [No Abstract] [Full Text] [Related]
18. Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma. Tsao MS, Liu N, Nicklee T, Shepherd F, Viallet J. Clin Cancer Res; 1997 Oct 01; 3(10):1807-14. PubMed ID: 9815567 [Abstract] [Full Text] [Related]
19. Angiogenesis in multiple myeloma. Sezer O, Niemöller K, Jakob C, Heider U. Leuk Res; 2002 Jul 01; 26(7):701-2. PubMed ID: 12008091 [No Abstract] [Full Text] [Related]